The global clinical
trial supplies market is expected to reach USD 3.3 billion by
2025, according to a new report by Grand View Research, Inc. The market is
expected to witness growth at 7.3% CAGR owing to Increasing volume of clinical
trial studies coupled with the growing complexity in conduction of these trials
are the primary driver of the industry. Furthermore, geographic expansion and
development of Information Technology (IT) to facilitate higher integration and
smooth performance of activities are other vitally impacting parameters. Over the
next eight years, the clinical trials and pharmaceutical industry is
anticipated to continue steady growth, thereby promoting the high requirement
of clinical trial supplies.
U.S and Canada are home to majority of clinical trials
which are conducted in this region. No language barrier is one of the major
factor for the preference of this region for majority of clinical trials, as
English language is widely spoken in this region. Major CRO’s and
biopharmaceutical companies have their hub in this region and with advancement
in technology the demand for efficient supplies are increasing and the region
is expected to dominate the clinical trial supplies market over the forecast period.
Browse full research report on Clinical Trial Supplies Market: https://www.grandviewresearch.com/industry-analysis/clinical-trial-supplies-market
Further
Key Findings From the Study Suggest:
- On the basis of clinical phase, the market is anticipated to be
dominated by Phase III in 2025. The presence of large number of molecule
estimated to reach Phase III by 2020 is the primary factor responsible for
this prediction.
- By services, storage and distribution is anticipated to witness the
fastest growth at a CAGR of over 7.0%.
- Key end-users of this industry are pharmaceuticals, and biologics.
Biologics are expected to witness fastest growth owing to the increasing
research in the field of genetics and biotechnology such as development of
nanoparticle based drug delivery systems.
- In terms of therapeutic use or clinical indication, oncology
dominates the market. The highest research activity as of 2016 is being
performed for this indication, which in turn is expected to drive the
market.
- Few of the industry players include Movianto GmbH, Thermo Fischer
Scientific, Sharp Packaging Services, Catalent Pharma Solution, Biocair
International Ltd., PCI Services, Almac Group Ltd, and Patheon Inc. Other
players present in the market space include Clinigen Group Plc, Merck
Serono, and Chimerix.
Browse more reports of this category
by Grand View Research: https://www.grandviewresearch.com/industry/pharmaceuticals
Grand
View Research has segmented the clinical trial supplies market by phase,
product/service, end-
use, therapeutic use and region:
Clinical
Phase Outlook (Revenue, USD Million; 2014 - 2025)
- Phase I
- Phase II
- Phase III
- Others
Product/Service
Outlook (Revenue, USD Million; 2014 - 2025)
- Manufacturing
- Storage &
distribution
- Cold chain
based
- Non-cold
chain based
- Supply chain
management
End-Use
Outlook (Revenue, USD Million; 2014 - 2025)
- Pharmaceuticals
- Biologics
- Medical
device
- Others
Therapeutic
Use Outlook (Revenue, USD Million; 2014 - 2025)
- Oncology
- CNS
- Cardiovascular
- Infectious
disease
- Metabolic
disorders
- Others
Regional
Outlook (Revenue, USD Million; 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia Pacific
- China
- Japan
- Latin America
- Mexico
- Brazil
- MEA
- South Africa
- Saudi Arabia
About Grand View
Research
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
No comments:
Post a Comment